Fundamental research for tomorrow’s patients

Cancer is still a massive problem. Nowadays it is the leading cause of death in The Netherlands and 1 out of 3 people is affected by it. Why haven’t we defeated cancer yet?

Elize Brolsma

We are making tremendous progress, but cancer keeps surprising us. For example, we understand more and more about the complexity of the different forms of cancer. Every cancer is unique. However, where one patient with colon cancer responds well to a treatment, another patient does not. Why? To find the answers to these kind of questions, we have to go back to the basics. That’s why we invest in fundamental research.

We do this fundamental research together. Over 800 researchers from 12 different institutes across The Netherlands collaborate intensively and exchange their knowledge and expertise. Oncode Institute translates the fundamental insights we obtain to new treatments as quickly as possible. Geert Kops, Scientific Director of Oncode, explains how in the video below:

World Cancer Day

Would you like to know more or do you have a suggestion? We like to hear from you.

Other Stories

Research Strategy
How fundamental oncology will shape future cancer treatment
Two researchers, Jeanine Roodhart and Henk Verhuel, try to predict which fundamental research paths are most likely to improve the life of cancer patients in the future
Hidde Boersma
Our Work Icon
Oncode Institute is at full strength with 19 new cancer researchers
We are pleased to announce that 19 excellent scientists and their research groups join Oncode Institute per 2019. Oncode grows to 62 research groups, spread over 12 academic institutions throughout The Netherlands.
Oncode 1 1
Highlights of the Oncode-CGC Annual Scientific meeting
On 10 and 11 January, Oncode and CGC researchers met at the Compagnie Theater in Amsterdam to enjoy, discuss and experience science. Apart from inspiring talks, the two-day event also offered other engaging ways to stimulate interaction.

Stay up to date